“The apprehension with utilizing non IID listed ingredients is justified as it can be not possible to evaluate if FDA would discover the ‘novel excipient’ Harmless to be used within a drug product as there's no defined system for evaluation and acceptance of excipients. The FDA assistance on ‘Nonclinical https://roselynek160axv3.bloggerbags.com/profile